ChemicalBook >> CAS DataBase List >>Bosentan hydrate

Bosentan hydrate

CAS No.
157212-55-0
Chemical Name:
Bosentan hydrate
Synonyms
CS-170;Bosetan;bosentan hydrate;Bosentan (200 mg);Bosentan (1076115);Bosentan monohydrate;Bosentan hydrate USP/EP/BP;Bosentan Hydrate See B675900;Bosentan Hydrate (Ro 47-0203);Tracleer, Bosentan monohydrate
CBNumber:
CB6547457
Molecular Formula:
C27H31N5O7S
Molecular Weight:
569.62934
MDL Number:
MFCD09751188
MOL File:
157212-55-0.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:00

Bosentan hydrate Properties

Melting point 114-118 °C
storage temp. 2-8°C
solubility DMSO (Slightly), Methanol (Very Slightly, Heated)
form powder
color white to beige
Merck 14,1353
FDA UNII Q326023R30

SAFETY

Risk and Safety Statements

Hazard statements  H412
Precautionary statements  P273
HS Code  2935909550

Bosentan hydrate price More Price(47)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML1265 Bosentan hydrate ≥98% (HPLC) 157212-55-0 10MG $108 2023-06-20 Buy
Sigma-Aldrich SML1265 Bosentan hydrate ≥98% (HPLC) 157212-55-0 50MG $438 2023-06-20 Buy
Sigma-Aldrich PHR2708 Bosentan certified reference material, pharmaceutical secondary standard 157212-55-0 500MG $349 2022-05-15 Buy
Sigma-Aldrich 1076115 Bosentan United States Pharmacopeia (USP) Reference Standard 157212-55-0 200MG $818 2022-05-15 Buy
TCI Chemical B5118 Bosentan Monohydrate >98.0%(HPLC) 157212-55-0 25mg $57 2024-03-01 Buy
Product number Packaging Price Buy
SML1265 10MG $108 Buy
SML1265 50MG $438 Buy
PHR2708 500MG $349 Buy
1076115 200MG $818 Buy
B5118 25mg $57 Buy

Bosentan hydrate Chemical Properties,Uses,Production

Uses

Antagonist (endothelin receptor).

Uses

Bosentan hydrate has been used in cell viability assay. It has also been used as a positive control for calcium transient analysis.

Definition

ChEBI: Bosentan hydrate is a hydrate. It contains a bosentan.

brand name

Tracleer (Actelion).

Biological Activity

a sulfonamide-derived, competitive and specific endothelin receptor antagonist with a relatively higher affinity to the endothelin a receptor than endothelin b receptor. by competitively binding to endothelin a and endothelin b receptors in the endothelium and vascular smooth muscle, bosentan offset the effect of endothelin which is an extremely potent endogenous vasoconstrictor and broncho-constrictor. in addition, bosentan decreases both pulmonary and systemic vascular resistance and is particularly applied in the treatment of pulmonary arterial hypertension. [1]

Biochem/physiol Actions

Bosentan is an endothelin receptor antagonist. Endothelin is a potent vasoconstrictor, making antagonists of clinical interest for the treatment of conditions associated with vasospasm, such as subarachnoid hemorrhage (SAH) and hypertension. Bosentan is a dual endothelin receptor antagonist effective in the treatment of pulmonary arterial hypertension (PAH), the first of the class to make it to market. Bosentan is an orally available, competitive antagonist of both the ETA and ETB receptor subtypes with a Ki of 4.7 nM for ETA and a Ki of 95 nM for ETB.

in vitro

a study was performed in vitro to measure the influence of bosentan on the angiogenic performance of dermal microvascular endothelial cells (mvecs) and to detect the capacity of bosentan in offsetting the antiangiogenic effects of systemic sclerosis sera. it was found that bosentan significantly increased cell viability and offset the antiangiogenic effects of systemic sclerosis sera on dermal mvecs. [2]

in vivo

a study was conducted to investigate the effect of bosentan on plasma leptin level after myocardial infarction in wistar rats. after oral administration of bosentan once daily at the dose of 100 mg/kg for 2 days, concentration of leptin in plasma significantly increased. this finding revealed that bosentan played an crucial role on regulating leptin concentration in ischemic cardiovascular pathology. [1]

IC 50

inhibiting endothelin receptor a and b with an ic50 of 15.1 ± 1.6 μm in p388/dx cells.

References

[1] ostrowski rp, januszewski sa, kowalska za and kapuscinski a. effect of endothelin receptor antagonist bosentan on plasma leptin concentration in acute myocardial infarction in rats. pathophysiology. 2003 sep; 9(4): 249-56.
[2]romano e, bellando-randone s, manetti m, bruni c, lepri g, matucci-cerinic m, guiducci s. bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study. clin exp rheumatol. 2015 aug; 33(4 suppl 91): s148-52.
[3]rubin lj, badesch db, barst rj, galiè n, black cm et, al. bosentan therapy for pulmonary arterial hypertension. new engl j med. 2002 mar; 346 (12): 896-903.

Bosentan hydrate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 361)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
HubeiwidelychemicaltechnologyCo.,Ltd
18627774460 faith@widelychemical.com CHINA 742 58
Shochem(Shanghai) Co.,Ltd
86-21-50800795 info@shochem.com CHINA 288 58
Chengdu Feibo Pharm Technology Co., Ltd
15982321820 abby@arkpharm.com CHINA 3279 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49390 58
Chengdu Aslee Biopharmaceuticals, Inc.
28-85305008 CHINA 964 58

View Lastest Price from Bosentan hydrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Bosentan hydrate pictures 2021-11-27 Bosentan hydrate
157212-55-0
US $0.20 / g 100g 99.99% 5ton/Month Qiuxian Baitai New Material Co., LTD
Bosentan hydrate pictures 2021-10-08 Bosentan hydrate
157212-55-0
US $0.00-0.00 / g 1g 98%+ 100kgs Wuhan Nutra Biotechnology Co.,Ltd
Bosentan hydrate pictures 2021-07-13 Bosentan hydrate
157212-55-0
US $15.00-10.00 / KG 1KG 99%+ HPLC Monthly supply of 1 ton Zhuozhou Wenxi import and Export Co., Ltd
  • Bosentan hydrate pictures
  • Bosentan hydrate
    157212-55-0
  • US $0.20 / g
  • 99.99%
  • Qiuxian Baitai New Material Co., LTD
  • Bosentan hydrate pictures
  • Bosentan hydrate
    157212-55-0
  • US $0.00-0.00 / g
  • 98%+
  • Wuhan Nutra Biotechnology Co.,Ltd
  • Bosentan hydrate pictures
  • Bosentan hydrate
    157212-55-0
  • US $15.00-10.00 / KG
  • 99%+ HPLC
  • Zhuozhou Wenxi import and Export Co., Ltd

Bosentan hydrate Spectrum

Bosetan 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfona 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-Methoxyphenoxy)-2-(pyriMidin-2-yl)pyriMidin-4-yl]benzene-1-sulfonaMide Bosentan Hydrate See B675900 Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-, hydrate (1:1) Bosentan (200 mg) bosentan hydrate Bosentan monohydrate 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)benzenesulfonamide monohydrate CS-170 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide hydrate Bosentan hydrate USP/EP/BP Bosentan Hydrate (Ro 47-0203) 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide hydrate[Ro-47-0203 Hydrate Bosentan MonohydrateQ: What is Bosentan Monohydrate Q: What is the CAS Number of Bosentan Monohydrate Q: What is the storage condition of Bosentan Monohydrate Q: What are the applications of Bosentan Monohydrate Bosentan HydrateQ: What is Bosentan Hydrate Q: What is the CAS Number of Bosentan Hydrate Q: What is the storage condition of Bosentan Hydrate Q: What are the applications of Bosentan Hydrate Bosentan (1076115) Tracleer, Bosentan monohydrate Bosentan Monohydrate/Bosentan Hydrate 4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide hydrate 157212-55-0 C27H29N5O6SH2O 9N5O6SH2O C27H31N5O7S C27H29N5O6S2O Inhibitors API Heterocyclic Compounds